Kyungjin Peter Kim, Ph.D.President, CEO at ST Pharm Co Ltd.
Expert in new drug discovery and development with over 30 years of academy and industrial
experience in metabolic disease, virology, inflammation and oncology therapeutic area
Extensive knowledge and experience with a proven track record of target validation, lead
optimisation library design, solid-phase synthesis and novel technology innovation (solidsupport
reagents, microwave, SFC, CFT, SMB, and etc.)
Skilled managing in new chemical entity CMO/CDMO manufacturing and non-clinical CRO